0

1

Dr. Weng highlights progress in retina treatments.

2

First treatment for macular telangiectasia type 2 approved.

3

Gene therapy options are expanding.

4

Home OCT system cleared for patient use.

5

Future will focus on personalized medicine.

6

Imaging biomarkers and genetic testing will guide treatment.

7

Ongoing clinical trials are crucial for advancing care.

8

AI technologies may customize patient treatment schedules.